Blue California Begins Production of Dihydroquercetin
The new antioxidant ingredient provides opportunities for formulation in anti-inflammatory supplements and personal care products, as well as food and beverage products in need of greater stability.
Photo © iStockphoto.com/Jacob Wackerhausen
Blue California (Rancho Santa Margarita) has begun commercial production of a new dihydroquercetin ingredient, BC-DHQ, which it says offers antioxidant benefits suitable for a variety of consumer products. That includes dietary supplements, cosmetics and personal care products, and food and beverage products that may benefit from the ingredient’s stabilizing properties.
Dihydroquercetin, a bioflavonoid found in many fruits and vegetables, has a “unique molecular structure which makes it especially effective at preventing cellular damage, and even induces other antioxidant enzymes to take preventative action as well,” according to Blue California. The firm says the ingredient has also been studied for its ability to protect cells from oxidation, as well as its ability to stimulate production of collagen and elastin in the skin. Additionally, the ingredient’s antioxidant properties makes it a “potential alternative for shelf-life extension, flavor enhancement, and color stabilization for the food and beverage industry,” Blue California says.
“The availability of this water-soluble antioxidant can bring enormous benefits to dietary supplements, cosmetics, and functional beverages,” says Cecilia McCollum, executive vice president of Blue California. “BC-DHQ can offer consumers added protection against premature aging, chronic inflammation, and other health problems related to oxidative stress.”
McCollum also notes that Blue California has begun work to obtain self-affirmed Generally Recognized as Safe status for its dihydroquercetin ingredient.
Read more:
First Natural L-Ergothioneine Antioxidant Now Sold Commercially
Back to Basics: Suppliers Focus on Whole-Food Vitamins, Minerals at SupplySide West
New Sports Nutrition Antioxidant Ingredient Protects Muscles, Firm Says
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
